Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer-Reference-Cited by-同舟云学术

Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer

Published:2012-10 Issue:10 Volume:43 Page:1688-1694
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Yamaguchi Rin,Tanaka Maki,Yano Ayako,Tse Gary M.,Yamaguchi Miki,Koura Keiko,Kanomata Naoki,Kawaguchi Atsushi,Akiba Jun,Naito Yoshiki,Ohshima Koichi,Yano Hirohisa

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference24 articles.

1. 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;Goldhirsch;Ann Oncol,2007

2. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update;Kaufmann;J Clin Oncol,2006

3. High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy;Osako;J Cancer Res Clin Oncol,2010

4. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy;Darb-Esfahani;Breast Cancer Res,2009

5. Lymphocyte infiltrates as a prognostic variable in female breast cancer;Aaltomaa;Eur J Cancer,1992

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

2. Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial;iScience;2024-08

3. Assessment of stromal tumor-infiltrating lymphocytes in neoadjuvant chemotherapy for invasive breast carcinoma: Predictive insights across molecular subtypes;Pathology - Research and Practice;2024-08

4. Physical and Psychological Stressors Increase Breast Tumor Growth but Differentially Alter Tumor Immunity;2024-07-25

5. Assessing the relationship between tumor-infiltrating lymphocytes and PD-L1 expression in triple negative breast cancer: Identifying optimal TILs cut-off value for pathologic reporting;Annals of Diagnostic Pathology;2024-06